326 related articles for article (PubMed ID: 25779941)
21. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
22. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.
Gillison ML; Castellsagué X; Chaturvedi A; Goodman MT; Snijders P; Tommasino M; Arbyn M; Franceschi S
Int J Cancer; 2014 Feb; 134(3):497-507. PubMed ID: 23568556
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
24. [Involvement of human papillomavirus in upper aero-digestive tracts cancers].
Neufcoeur PE; Arafa M; Delvenne P; Saussez S
Bull Cancer; 2009 Oct; 96(10):941-50. PubMed ID: 19744917
[TBL] [Abstract][Full Text] [Related]
25. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma.
Marsit CJ; McClean MD; Furniss CS; Kelsey KT
Int J Cancer; 2006 Oct; 119(8):1761-6. PubMed ID: 16708382
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Schultz JD; Sommer JU; Hoedt S; Erben P; Hofheinz RD; Faber A; Thorn C; Hörmann K; Sauter A
Oncol Rep; 2012 Jan; 27(1):270-80. PubMed ID: 21993766
[TBL] [Abstract][Full Text] [Related]
28. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
[TBL] [Abstract][Full Text] [Related]
29. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
30. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 in head and neck carcinogenesis.
Chen R; Aaltonen LM; Vaheri A
Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978
[TBL] [Abstract][Full Text] [Related]
32. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications.
Gavid M; Pillet S; Pozzetto B; Oriol M; Dumollard JM; Timoshenko AP; Martin C; Prades JM
Acta Otolaryngol; 2013 May; 133(5):538-43. PubMed ID: 23350597
[TBL] [Abstract][Full Text] [Related]
34. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
36. TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.
Levovitz C; Chen D; Ivansson E; Gyllensten U; Finnigan JP; Alshawish S; Zhang W; Schadt EE; Posner MR; Genden EM; Boffetta P; Sikora AG
Cancer Res; 2014 Dec; 74(23):6833-44. PubMed ID: 25273091
[TBL] [Abstract][Full Text] [Related]
37. Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.
Qin Y; Ekmekcioglu S; Forget MA; Szekvolgyi L; Hwu P; Grimm EA; Jazaeri AA; Roszik J
Front Immunol; 2017; 8():689. PubMed ID: 28670312
[TBL] [Abstract][Full Text] [Related]
38. The landscape of viral associations in human cancers.
Zapatka M; Borozan I; Brewer DS; Iskar M; Grundhoff A; Alawi M; Desai N; Sültmann H; Moch H; ; Cooper CS; Eils R; Ferretti V; Lichter P;
Nat Genet; 2020 Mar; 52(3):320-330. PubMed ID: 32025001
[TBL] [Abstract][Full Text] [Related]
39. The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.
Morris LGT; Chandramohan R; West L; Zehir A; Chakravarty D; Pfister DG; Wong RJ; Lee NY; Sherman EJ; Baxi SS; Ganly I; Singh B; Shah JP; Shaha AR; Boyle JO; Patel SG; Roman BR; Barker CA; McBride SM; Chan TA; Dogan S; Hyman DM; Berger MF; Solit DB; Riaz N; Ho AL
JAMA Oncol; 2017 Feb; 3(2):244-255. PubMed ID: 27442865
[TBL] [Abstract][Full Text] [Related]
40.
Kato S; Subbiah V; Marchlik E; Elkin SK; Carter JL; Kurzrock R
Clin Cancer Res; 2017 Apr; 23(8):1988-1997. PubMed ID: 27683183
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
